ConductScience.org, home

Paper10543733

Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.

Mirochnick M and 16 others. Antimicrob Agents Chemother, 1999. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children. Papers, record 10543733. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10543733

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1999
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.49
iCite
Revised in PubMed
2020-07-24
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mirochnick MM
2Cooper EE
3McIntosh KK
4Xu JJ
5Lindsey JJ
6Jacobus DD
7Mofenson LL
8Sullivan JLJ L
9Dankner WW
10Frenkel LML M
11Nachman SS
12Wara DWD W
13Johnson DD
14Bonagura VRV R
15Rathore MHM H
16Cunningham CKC K
17McNamara JJ

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Infective AgentsMajor topic
DapsoneMajor topic
HIV InfectionsMajor topic
Adolescent
Child
Child, Preschool
Chromatography, High Pressure Liquid
Female
Humans
Infant
Male
Pneumonia, Pneumocystis

Source PubMed

Download CSV of topics

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17380899Rapid high-performance liquid chromatographic method for the determination of dapsone and monoacetyldapsone in biological fluids.J Chromatogr1980https://conductscience.org/library/papers/7380899PubMed
29469685Update: clinically significant cytochrome P-450 drug interactions.Pharmacotherapy1998https://conductscience.org/library/papers/9469685PubMed
33530584Clinical pharmacokinetics of dapsone.Clin Pharmacokinet1986https://conductscience.org/library/papers/3530584PubMed
43623744The absolute oral bioavailability of dapsone in dogs and humans.Int J Clin Pharmacol Ther Toxicol1987https://conductscience.org/library/papers/3623744PubMed
53260765Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3260765PubMed
61977035Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone.Lancet1990https://conductscience.org/library/papers/1977035PubMed
72249373The contribution of N-hydroxylation and acetylation to dapsone pharmacokinetics in normal subjects.Clin Pharmacol Ther1990https://conductscience.org/library/papers/2249373PubMed
81672036Guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with human immunodeficiency virus.MMWR Recomm Rep1991https://conductscience.org/library/papers/1672036PubMed
98496767Pharmacokinetics of dapsone in children.J Pediatr1993https://conductscience.org/library/papers/8496767PubMed
108513654The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans.Clin Pharmacol Ther1993https://conductscience.org/library/papers/8513654PubMed
117625796Pharmacokinetics of dapsone in human immunodeficiency virus-infected children.Antimicrob Agents Chemother1995https://conductscience.org/library/papers/7625796PubMed
127565543
1995 revised guidelines for prophylaxis against Pneumocystis carinii pneumonia for children infected with or perinatally exposed to human immunodeficiency virus. National Pediatric and Family HIV Resource Center and National Center for Infectious Diseases, Centers for Disease Control and Prevention.
MMWR Recomm Rep1995https://conductscience.org/library/papers/7565543PubMed
139124833Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.Antimicrob Agents Chemother1996https://conductscience.org/library/papers/9124833PubMed
149057784Pharmacogenetics in pediatrics. Implications for practice.Pediatr Clin North Am1997https://conductscience.org/library/papers/9057784PubMed
1592147021997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group.MMWR Recomm Rep1997https://conductscience.org/library/papers/9214702PubMed
166620166Computation of model-independent pharmacokinetic parameters during multiple dosing.J Pharm Sci1983https://conductscience.org/library/papers/6620166PubMed

Download CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
39289236Development, Pharmacokinetics and Antimalarial Evaluation of Dose Flexible 3D Printlets of Dapsone for Pediatric Patients.AAPS PharmSciTech2024https://conductscience.org/library/papers/39289236PubMed
37489004Non-compartmental and population pharmacokinetic analysis of dapsone in healthy NIGERIANS: A pilot study.Br J Clin Pharmacol2023https://conductscience.org/library/papers/37489004PubMed
24569199
Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
Pediatr Infect Dis J2013https://conductscience.org/library/papers/24569199PubMed
19730409
Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.
MMWR Recomm Rep2009https://conductscience.org/library/papers/19730409PubMed
16487222Population pharmacokinetic and pharmacodynamic modelling of the antimalarial chemotherapy chlorproguanil/dapsone.Br J Clin Pharmacol2006https://conductscience.org/library/papers/16487222PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10543733

GET https://conductscience.org/api/papers/v1/10543733/authors